SCHEMBL23840607

SCHEMBL23840607

C=C(Nc1cnc(OC)c(S(=O)(=O)Nc2ccc(Cl)cc2)c1)c1cccc(N2CCCC2=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 5/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 2/20 0.41
TSHR P16473 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
F10 P00742 3/20 0.40
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 3/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
IDH1 O75874 2/20 0.39
GAA P10253 2/20 0.38
ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25482879 0.92 NPC1 (0.52) NPC1SMN1; SMN2HTTRAB9AKMT2A
SCHEMBL23840307 0.76 EGFR (0.44) SMN1; SMN2HTTKMT2AMEN1L3MBTL1
SCHEMBL23840608 0.76 IDH1 (0.42) NPC1SMN1; SMN2HTTRAB9AKMT2A
SCHEMBL23840621 0.75 MEN1 (0.52) NPC1SMN1; SMN2HTTRAB9AKMT2A
SCHEMBL23840604 0.75 ITGA1 (0.45) SMN1; SMN2HTTKMT2AMEN1ALDH1A1
SCHEMBL23840640 0.74 BRD4 (0.49) IDH1
SCHEMBL23840609 0.73 SMN1; SMN2 (0.40) SMN1; SMN2KMT2AMEN1L3MBTL1ALDH1A1
SCHEMBL23840603 0.73 ALDH1A1 (0.46) NPC1SMN1; SMN2RAB9AKMT2AMEN1
SCHEMBL23833491 0.72 EGFR (0.51) SMN1; SMN2HTTKMT2AMEN1IDH1
SCHEMBL30151007 0.72 EGFR (0.51) SMN1; SMN2HTTKMT2AMEN1IDH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188907-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed